Companies in #BK Virus

Memo Therapeutics is a Swiss clinical-stage biotech developing antibody-based therapies for viral infections and cancer. Its lead asset is anti-BK virus (BKV) antibody for kidney transplant recipients, with additional programs in CMV and oncology.